IMM.L Gross Margin

As of 2025-05-21, the Gross Margin of ImmuPharma PLC (IMM.L) is 100%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

IMM.L Gross Margin - Historical Value

Date	Value
2023-12-31	100%
2022-12-31	-
2021-12-31	-
2020-12-31	-
2019-12-31	-
2018-12-31	-
2017-12-31	-
2016-12-31	-
2015-12-31	-
2014-12-31	-

IMM.L Gross Margin - Peers Comparison

Ticker	Name	Value
AB.PA	AB Science SA	60.5%
ALTHX.PA	Theranexus SA	-217.6%
ALZCUR.ST	AlzeCure Pharma AB	7775.2%
ANNX.ST	Annexin Pharmaceuticals AB (publ)	7775.2%
APH.L	Alliance Pharma PLC	61.1%
ARTL	Artelo Biosciences Inc	7775.2%
ASAP.ST	Asarina Pharma AB (publ)	7775.2%
AVCN.TO	Avicanna Inc	45.4%
AZN.L	AstraZeneca PLC	82.1%
CLBIO.ST	Corline Biomedical AB	137.5%
CXRXF	Advanz Pharma Corp Ltd	63.4%
DDDD.L	4D Pharma PLC	-
DPH.L	Dechra Pharmaceuticals PLC	56.4%
ERMA.ST	Enorama Pharma AB	23.5%
FUM.L	Futura Medical PLC	69.6%
GABA.ST	Gabather AB	7775.2%
GSK.L	GSK plc	71.9%
GWPRF	GW Pharmaceuticals PLC	91.3%
HIK.L	Hikma Pharmaceuticals PLC	45.9%
HRTIS.HE	Herantis Pharma Oyj	-7.1%
INDV.L	Indivior PLC	85.3%
KDEV.ST	Karolinska Development AB	-350.1%
KLAR.ST	Klaria Pharma Holding AB (publ)	100%
LIPI.ST	Lipidor AB	-82.3%
MOB.ST	Moberg Pharma AB (publ)	64.4%
MTFB.L	Motif Bio PLC	-
NFX.L	Nuformix PLC	96.6%
NWRN.SW	Newron Pharmaceuticals SpA	98.3%
REDX.L	Redx Pharma PLC	88.8%
SAR.L	Sareum Holdings PLC	-41.3%
SKIN.SW	Cassiopea SpA	100%
STX.L	Shield Therapeutics PLC	30.8%
TCCR	Triccar Inc	37.7%
TMBR	Timber Pharmaceuticals Inc	-50%
UROV	Urovant Sciences Ltd	-
VEC.L	Vectura Group PLC	5320%